NCT07365995
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07365995
Title A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors BioNTech SE
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Maryland Oncology Hematology RECRUITING Rockville Maryland 20850 United States Details
SCRI Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
Texas Oncology South Austin RECRUITING Austin Texas 78731 United States Details
Texas Oncology Gulf Coast RECRUITING Houston Texas 77024 United States Details
Texas Oncology, P.A. - Tyler RECRUITING Tyler Texas 75702 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field